The association between various diseases and the existence or neosynthesis of certain carbohydrate antigen structures has been given special attention in recent years. Several of these carbohydrate structures are blood group antigens, among which particular interest has been given to the Lewis antigen system.
Compared to other erythrocyte blood-group systems the Lewis blood group system is unique as the Lewis active glycolipids are not synthesised in the erythrocytes but acquired from plasma (Sneath & Sneath, 1959; Marr et al., 1967; Marcus & Cass, 1969) . The Lea antigen determinant GlcNAc-R) is synthesised by the action of an al-4-L-fucosyltransferase encoded by the Lewis gene (Shen, Grollman & Ginsburg, 1968) , and the activity of this enzyme can be determined in saliva. The Leb antigen determinant GlcNAc-R) is formed by the sequential action of an al-2-L-fucosyltransferase and the a 1 -4-L-fucosyltransferase (Grollman, Kobata & Ginsburg, 1989 ).
Several investigations have described an incompatibility of
Lewis erythrocyte phenotype and saliva or serum Lewis antigens associated with different pathologic conditions. One study showed the prevalence of erythrocyte Laa -bphenotype to be significantly higher in patients with pancreatic cancer than normal controls (Hirano et al., 1987) . Another study has shown that 11 out of 18 patients studied, predominantly with gastrointestinal cancers, had inappropriate Lewis blood group antigens in their erythrocytes and saliva, with an increased frequency of the Lea -b -phenotype among these patients (Yazawa et al., 1988) . In addition, pregnant women and patients with alcoholic cirrhosis and alcoholic pancreatitis seem to lose their Lewis phenotype on erythrocytes (Hammar et al., 1981; Stigendal et al., 1984 
in patients suffering from carcinoma of the bladder and colon to the distribution found in normal controls, and to correlate the different phenotypes to biological parameters like stage, pathologic grade and invasion.
Materials and methods
Patients and samples Ten ml samples of human whole blood were obtained from 82 patients suffering from urinary bladder carcinomas, 21 patients suffering from carcinoma of the colon (Table III) , 26 patients suffering from hyperplasia of the prostate, and from 19 patients suffering from chronic cystitis ( Table IV) . The samples were used for serology within 24 h. Saliva samples were obtained simultaneously with the blood samples from some of the patients. One ml saliva was stored at -80°C for enzyme analysis and I ml was stored at -20°C for hemagglutination inhibition tests.
Pathology
Data on the grade of atypia (Bergkvist et al., 1965) The distribution of ABO and Lewis phenotypes among colon and bladder cancer patients is shown in Table I . No statistically significant differences in the distribution of ABO phenotypes were found between cancer patients and the volunteer donor population, whereas the incidence of Lea bphenotype among colon cancer (23.8%) and bladder cancer patients (12.2%) was significantly higher when compared to the volunteer donor population (7.1 %) (P < 0.003 and P = 0.05, respectively) ( Table I ). The distribution of ABO and Lewis phenotypes among patients suffering from the benign diseases hypertrophia of the prostate and chronic cystitis (Table II) was not significantly different from the distribution found in the volunteer donor population. (Race & Sanger, 1975; Mollison et al., 1987; Issitt, 1985 offer an explanation of the observed over-representation of erythrocyte Lewis negative individuals among patients with colon and bladder cancer. Sheinfeld et al. found an increased frequency of Lea -band Lea + b -phenotypes among white women with recurrent urinary tract infections (Sheinfeld et al., 1989) . This result seems at first view to conflict with the results presented here (Table II) , but is explained by the fact that two different (Schoentag et al., 1987; Itzkowitz et al., 1986; Yazawa et al., 1986; Hammar et al., 1989) . The finding of serum Lewis antigen levels in non-genuine Lewis negative individuals identical to the ones found in Lewis positive individuals (0rntoft et al., 1989) , enforces the idea that the process by which erythrocytes take up Lewis active glycolipids might be disturbed. Further studies are needed to reveal the mechanism of the changing of Lewis phenotype on erythrocytes.
The findings described here along with similar previous observations (Hirano et al., 1987; Yazawa et al., 1988) indicate that alterations in the expression of Lewis antigens is a cancer-associated phenomenon. We conclude that the frequency of the erythrocyte Le' b -phenotype is increased in patients who suffer from colorectal and bladder carcinomasespecially so in high grade invasive cases. This is probably not to be explained by an increased risk of bladder cancer among erythrocyte Lea b -individuals, but by the fact that individuals who are normally erythrocyte Lewis positive become erythrocyte Lewis negative when they get an invasive cancer. 
